{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:38:04Z","timestamp":1790858284586,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,9,29]],"date-time":"2005-09-29T00:00:00Z","timestamp":1127952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,9,29]],"date-time":"2005-09-29T00:00:00Z","timestamp":1127952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1038\/sj.leu.2403967","type":"journal-article","created":{"date-parts":[[2005,9,29]],"date-time":"2005-09-29T07:49:02Z","timestamp":1127980142000},"page":"2304-2312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":403,"title":["Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)"],"prefix":"10.1038","volume":"19","author":[{"given":"M","family":"Aoudjhane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Labopin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N C","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Shimoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Ruutu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-J","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Frassoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Boiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Finke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Shouten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Blaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Falda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A A","family":"Fauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Esteve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Polge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Niederwieser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Acute Leukemia Working Party of EBMT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,9,29]]},"reference":[{"key":"BF2403967_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.1993.03510010063030","volume":"270","author":"O Ringden","year":"1993","unstructured":"Ringden O, Horowitz MM, Gale RP, Biggs JC, Gajewski J, Rimm AA et al. Outcome after allogeneic bone marrow transplant for leukemia in older adults. JAMA 1993; 270: 57\u201360.","journal-title":"JAMA"},{"key":"BF2403967_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1046\/j.1365-2141.2000.02196.x","volume":"111","author":"R Champlin","year":"2000","unstructured":"Champlin R, Khouri I, Shimoni A, Gajewski J, Kornblau S, Molldrem J et al. Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy. Br J Haematol 2000; 111: 18\u201329.","journal-title":"Br J Haematol"},{"key":"BF2403967_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s11912-000-0084-y","volume":"2","author":"A Shimoni","year":"2000","unstructured":"Shimoni A, Giralt S, Khouri I, Champlin R . Allogeneic hematopoietic transplantation for acute and chronic myeloid leukemia: non-myeloablative preparative regimens and induction of the graft-versus-leukemia effect. Curr Oncol Rep 2000; 2: 132\u2013139.","journal-title":"Curr Oncol Rep"},{"key":"BF2403967_CR4","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1038\/sj.leu.2402316","volume":"15","author":"A Shimoni","year":"2001","unstructured":"Shimoni A, Nagler A . Non-myeloablative stem cell transplantation (NST): chimerism testing as guidance for immune-therapeutic manipulations. Leukemia 2001; 15: 1967\u20131975.","journal-title":"Leukemia"},{"key":"BF2403967_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-4615-0919-6_6","volume":"110","author":"A Shimoni","year":"2002","unstructured":"Shimoni A, Nagler A . Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice. Cancer Treat Res 2002; 110: 113\u2013136.","journal-title":"Cancer Treat Res"},{"key":"BF2403967_CR6","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1200\/JCO.2003.09.110","volume":"21","author":"H Bertz","year":"2003","unstructured":"Bertz H, Potthoff K, Finke J . Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia. J Clin Oncol 2003; 21: 1480\u20131484.","journal-title":"J Clin Oncol"},{"key":"BF2403967_CR7","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","volume":"89","author":"S Giralt","year":"1997","unstructured":"Giralt S, Estey E, Albitar M, van Besien K, Rondon G, Anderlini P et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood 1997; 89: 4531\u20134536.","journal-title":"Blood"},{"key":"BF2403967_CR8","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","volume":"97","author":"PA McSweeney","year":"2001","unstructured":"McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390\u20133400.","journal-title":"Blood"},{"key":"BF2403967_CR9","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E, Kapelushnik Y, Aker M, Cividalli G et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756\u2013763.","journal-title":"Blood"},{"key":"BF2403967_CR10","unstructured":"Slavin S, Aker M, Shapira MY, Resnick I, Bitan M, Or R . Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders. Clin Transpl 2003, 275\u2013282."},{"key":"BF2403967_CR11","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1097\/01.TP.0000129810.77790.EF","volume":"78","author":"S Slavin","year":"2004","unstructured":"Slavin S . Reduced intensity vs truly nonmyeloablative conditioning for stem-cell transplant recipients. Transplantation 2004; 78: 964\u2013965.","journal-title":"Transplantation"},{"key":"BF2403967_CR12","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1182\/blood-2003-03-0855","volume":"102","author":"R Wong","year":"2003","unstructured":"Wong R, Giralt SA, Martin T, Couriel DR, Anagnostopoulos A, Hosing C et al. Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years. Blood 2003; 102: 3052\u20133059.","journal-title":"Blood"},{"key":"BF2403967_CR13","first-page":"242","volume":"3","author":"A Shimoni","year":"2004","unstructured":"Shimoni A, Nagler A . Nonmyeloablative stem cell transplantation: lessons from the first decade of clinical experience. Curr Hematol Rep 2004; 3: 242\u2013248.","journal-title":"Curr Hematol Rep"},{"key":"BF2403967_CR14","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1182\/blood-2004-05-1947","volume":"105","author":"EP Alyea","year":"2005","unstructured":"Alyea EP, Kim HT, Ho V, Cutler C, Gribben J, DeAngelo DJ et al. Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age. Blood 2005; 105: 1810\u20131814.","journal-title":"Blood"},{"key":"BF2403967_CR15","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1182\/blood-2004-06-2387","volume":"105","author":"C Crawley","year":"2005","unstructured":"Crawley C, Lalancette M, Szydlo R, Gilleece M, Peggs K, Mackinnon S et al. Outcomes for reduced intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the chronic leukemia working party of the EBMT. Blood 2005; 105: 4532\u20134539.","journal-title":"Blood"},{"key":"BF2403967_CR16","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/sj.leu.2403770","volume":"19","author":"M Mohty","year":"2005","unstructured":"Mohty M, de Lavallade H, Ladaique P, Faucher C, Vey N, Coso D et al. The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison. Leukemia 2005; 19: 916\u2013920.","journal-title":"Leukemia"},{"key":"BF2403967_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/01.moh.0000148762.05110.56","volume":"12","author":"L Burroughs","year":"2005","unstructured":"Burroughs L, Storb R . Low-intensity allogeneic hematopoietic stem cell transplantation for myeloid malignancies: separating graft-versus-leukemia effects from graft-versus-host disease. Curr Opin Hematol 2005; 12: 45\u201354.","journal-title":"Curr Opin Hematol"},{"key":"BF2403967_CR18","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/(SICI)1097-0258(19990630)18:12<1489::AID-SIM140>3.0.CO;2-#","volume":"18","author":"PK Andersen","year":"1999","unstructured":"Andersen PK, Klein JP, Zhang MJ . Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. Stat Med 1999; 18: 1489\u20131500.","journal-title":"Stat Med"},{"key":"BF2403967_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/BF00985760","volume":"1","author":"P Hoogard","year":"1995","unstructured":"Hoogard P . Frailty model for survival data. Lifetime Data Anal 1995; 1: 255\u2013273.","journal-title":"Lifetime Data Anal"},{"key":"BF2403967_CR20","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","volume":"18","author":"TA Gooley","year":"1999","unstructured":"Gooley TA, Leisenring W, Crowley J, Storer BE . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999; 18: 695\u2013706.","journal-title":"Stat Med"},{"key":"BF2403967_CR21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","volume":"94","author":"JP Fine","year":"1999","unstructured":"Fine JP, Gray RJ . A proportional hazards model for subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496\u2013509.","journal-title":"J Am Stat Assoc"},{"key":"BF2403967_CR22","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1182\/blood-2004-03-0804","volume":"104","author":"R Diaconescu","year":"2004","unstructured":"Diaconescu R, Flowers CR, Storer B, Sorror ML, Maris MB, Maloney DG et al. Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. Blood 2004; 104: 1550\u20131558.","journal-title":"Blood"},{"key":"BF2403967_CR23","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1182\/blood-2004-02-0545","volume":"104","author":"ML Sorror","year":"2004","unstructured":"Sorror ML, Maris MB, Storer B, Sandmaier BM, Diaconescu R, Flowers C et al. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities. Blood 2004; 104: 961\u2013968.","journal-title":"Blood"},{"key":"BF2403967_CR24","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.bbmt.2005.01.003","volume":"11","author":"JW Chien","year":"2005","unstructured":"Chien JW, Maris MB, Sandmaier BM, Maloney DG, Storb RF, Clark JG . Comparison of lung function after myeloablative and 2\u2009Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005; 11: 288\u2013296.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF2403967_CR25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555\u2013562.","journal-title":"Blood"},{"key":"BF2403967_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3109\/10428199609045715","volume":"24","author":"O Ringden","year":"1996","unstructured":"Ringden O, Hermans J, Labopin M, Apperley J, Gorin NC, Gratwohl A . The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation (EBMT). Leuk Lymphoma 1996; 24: 71\u201379.","journal-title":"Leuk Lymphoma"},{"key":"BF2403967_CR27","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1182\/blood-2002-08-2628","volume":"102","author":"M Mielcarek","year":"2003","unstructured":"Mielcarek M, Martin PJ, Leisenring W, Flowers ME, Maloney DG, Sandmaier BM et al. Graft-versus-host disease after nonmyeloablative vs conventional hematopoietic stem cell transplantation. Blood 2003; 102: 756\u2013762.","journal-title":"Blood"},{"key":"BF2403967_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/sj.bmt.1704767","volume":"35","author":"ME Flowers","year":"2005","unstructured":"Flowers ME, Traina F, Storer B, Maris M, Bethge WA, Carpenter P et al. Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning. Bone Marrow Transplant 2005; 35: 277\u2013282.","journal-title":"Bone Marrow Transplant"},{"key":"BF2403967_CR29","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1200\/JCO.2005.08.136","volume":"23","author":"F Baron","year":"2005","unstructured":"Baron F, Maris MB, Sandmaier BM, Storer BE, Sorror M, Diaconescu R et al. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J Clin Oncol 2005; 23: 1993\u20132003.","journal-title":"J Clin Oncol"},{"key":"BF2403967_CR30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.bbmt.2003.10.006","volume":"10","author":"DR Couriel","year":"2004","unstructured":"Couriel DR, Saliba RM, Giralt S, Khouri I, Andersson B, de Lima M et al. Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation. Biol Blood Marrow Transplant 2004; 10: 178\u2013185.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BF2403967_CR31","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/sj.leu.2402034","volume":"15","author":"R Storb","year":"2001","unstructured":"Storb R . Nonmyeloablative preparative regimens: how relevant for acute myelogenous leukemia? Leukemia 2001; 15: 662\u2013663.","journal-title":"Leukemia"},{"key":"BF2403967_CR32","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/sj.leu.2403730","volume":"19","author":"FR Kerbauy","year":"2005","unstructured":"Kerbauy FR, Storb R, Hegenbart U, Gooley T, Shizuru J, Al Ali HK et al. Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML. Leukemia 2005; 19: 990\u2013997.","journal-title":"Leukemia"},{"key":"BF2403967_CR33","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1200\/JCO.2005.04.569","volume":"23","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Sandmaier BM, Storer BE, Stuart MJ, Hegenbart U et al. Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia. J Clin Oncol 2005; 23: 3819\u20133829.","journal-title":"J Clin Oncol"},{"key":"BF2403967_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/sj.leu.2403591","volume":"19","author":"A Shimoni","year":"2005","unstructured":"Shimoni A, Kroger N, Zabelina T, Ayuk F, Hardan I, Yeshurun M et al. Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age &gt;55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning. Leukemia 2005; 19: 7\u201312.","journal-title":"Leukemia"},{"key":"BF2403967_CR35","first-page":"111","volume":"18","author":"NC Gorin","year":"1996","unstructured":"Gorin NC, Labopin M, Fouillard L, Meloni G, Frassoni F, Iriondo A et al. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukaemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1996; 18: 111\u2013117.","journal-title":"Bone Marrow Transplant"},{"key":"BF2403967_CR36","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1016\/S0140-6736(00)02137-1","volume":"355","author":"F Frassoni","year":"2000","unstructured":"Frassoni F, Labopin M, Powles R, Mary JY, Arcese W, Bacigalupo A et al. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 2000; 355: 1393\u20131398.","journal-title":"Lancet"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403967.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403967","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403967.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:50:13Z","timestamp":1648763413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,29]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["BF2403967"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403967","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,29]]},"assertion":[{"value":"30 May 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}